Helen Kourlas

Summary

Affiliation: Long Island University
Country: USA

Publications

  1. ncbi request reprint Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review
    Helen Kourlas
    Division of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York 11201 5497, USA
    Clin Ther 28:36-44. 2006
  2. ncbi request reprint Ranibizumab for the treatment of neovascular age-related macular degeneration: a review
    Helen Kourlas
    Department of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York 11201, USA
    Clin Ther 29:1850-61. 2007

Detail Information

Publications2

  1. ncbi request reprint Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review
    Helen Kourlas
    Division of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York 11201 5497, USA
    Clin Ther 28:36-44. 2006
    ..The pharmacology, pharmacokinetics, pharmacodynamics, contraindications, and drug-interaction potential of pegaptanib are discussed, and the results of clinical trials evaluating its efficacy and tolerability are summarized...
  2. ncbi request reprint Ranibizumab for the treatment of neovascular age-related macular degeneration: a review
    Helen Kourlas
    Department of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York 11201, USA
    Clin Ther 29:1850-61. 2007
    ..The actions of ranibizumab result in reduced cell proliferation, reduced formation of new blood vessels, and minimization of vascular leakage...